Report an error
Spotted something inaccurate in “Evolocumab Cuts MACE Risk in Diabetic Patients Free of Known Atherosclerosis”? Tell us what’s wrong and we’ll check it against the original source.
This form is for factual corrections. We read every report but cannot reply individually.